Skip to main content
. 2021 Dec 8;15:753995. doi: 10.3389/fnint.2021.753995

TABLE 3.

Antiepileptic and psychiatric medications in use.

Medications in use Active tDCS
(n = 13)
Sham tDCS
(n = 13)
p value
Antiepileptic medications
Valproic acid (n, %) 2 (15.4%) 5 (38.5%) 0.37
Carbamazepine (n, %) 7 (53.8%) 9 (69.2%) 0.68
Clobazam (n, %) 1 (7.7%) 1 (7.7%) 1.00
Phenytoin (n, %) 3 (23.1%) 2 (15.4%) 1.00
Phenobarbital (n, %) 3 (23.1%) 4 (30.8%) 1.00
Lamotrigine (n, %) 0 (0%) 1 (7.7%) 1.00
Oxcarbazepine (n, %) 2 (15.4%) 0 (0%) 0.48
Psychiatric medications
Amitriptyline (n, %) 2 (15.4%) 1 (7.7%) 1.00
Benzodiazepine (n, %) 1 (7.7%) 1 (7.7%) 1.00
Chlorpromazine (n, %) 0 (0%) 2 (15.4%) 0.48
Fluoxetine (n, %) 5 (38.5%) 4 (30.8%) 1.00
Imipramine (n, %) 0 (0%) 2 (15.4%) 0.48
Lithium (n, %) 0 (0%) 1 (7.7%) 1.00
Risperidone (n, %) 0 (0%) 1 (7.7%) 1.00
Sertraline (n, %) 1 (7.7%) 1 (7.7%) 1.00